购物车
- 全部删除
- 您的购物车当前为空
TPOP146 is a selective CBP/P300 benzoxazepine bromodomain inhibitor (Kd: 134 nM and 5.02 μM for CBP and BRD4).
为众多的药物研发团队赋能,
让新药发现更简单!
TPOP146 is a selective CBP/P300 benzoxazepine bromodomain inhibitor (Kd: 134 nM and 5.02 μM for CBP and BRD4).
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
2 mg | ¥ 530 | 5日内发货 | |
5 mg | ¥ 872 | 10-14周 | |
10 mg | ¥ 1,490 | 10-14周 | |
100 mg | ¥ 6,650 | 10-14周 | |
1 mL x 10 mM (in DMSO) | ¥ 922 | 10-14周 |
产品描述 | TPOP146 is a selective CBP/P300 benzoxazepine bromodomain inhibitor (Kd: 134 nM and 5.02 μM for CBP and BRD4). |
靶点活性 | BRD4:5.02 μM, CBP:134 nM |
分子量 | 481.58 |
分子式 | C27H35N3O5 |
CAS No. | 2018300-62-2 |
密度 | 1.24 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容